MedTrace Logo

Black Garlic Nutraceuticals and Blood Pressure Control

NCT04915053 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-06-07

No results posted yet for this study

Summary

Black garlic contains a series of allyl-sulfur compounds with the ability to modulate nitric oxide synthetase, angiotensin-converting enzyme system, and endothelial activation, which together could help better control blood pressure. The main objective of this study is to evaluate the effect on blood pressure and endothelial health of a daily intake of a black garlic supplement named ABG (registered mark), which has a higher concentration of black garlic bioactive compounds, in people with moderate hypertension.

Conditions

Interventions

DIETARY_SUPPLEMENT

ABG+ Black Garlin

Daily tablet intake during three months

DIETARY_SUPPLEMENT

Crystalline Cellulose

Daily tablet intake during three months

Sponsors & Collaborators

  • Pharmactive, S.L.

    collaborator UNKNOWN

  • Universitat de Lleida

    lead OTHER

Principal Investigators

  • Manuel S Portero, PhD · Universitat de Lleida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-15
Primary Completion
2021-12-31
Completion
2022-06-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04915053 on ClinicalTrials.gov